Increased plasma pro-B-type natriuretic peptide in infants of women with type I diabetes

Clinical Chemistry

Volumn 51, Issue 12, 2005, Pages 2296-2302

  Halse, Karen G ^a   Lindegaard, Marie L S ^a   Goetze, Jens P ^a   Damm, Peter ^a   Mathiesen, Elisabeth R ^a   Nielsen, Lars B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN A1C; PRO BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FETUS RISK; HEART FAILURE; HUMAN; HYPOXIA; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LABOR; PERINATAL PERIOD; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; NATRIURETIC PEPTIDE, BRAIN; PREGNANCY; PREGNANCY IN DIABETICS; PROTEIN PRECURSORS;

EID: 28044448056     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.056077     Document Type: Article

References (34)

1. Lauenborg J, Mathiesen E, Ovesen P, Westergaard JG, Ekbom P, Molsted-Pedersen L, et al. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 2003;26:1385-9.
2. Abu-Sulaiman RM, Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol 2004;25:137-40.
3. Sardesai MG, Gray AA, McGrath MM, Ford SE. Fatal hypertrophic cardiomyopathy in the fetus of a woman with diabetes. Obstet Gynecol 2001;98:925-7.
4. Vela-Huerta MM, Vargas-Origel A, Olvera-Lopez A. Asymmetrical septal hypertrophy in newborn infants of diabetic mothers. Am J Perinatol 2000;17:89-94.
5. Sheehan PQ, Rowland TW, Shah BL, McGravey VJ, Reiter EO. Maternal diabetic control and hypertrophic cardiomyopathy in infants of diabetic mothers. Clin Pediatr (Phila) 1986;25:266-71.
6. Salvesen DR, Brudenell JM, Snijders RJ, Ireland RM, Nicolaides KH. Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 1993;168:88-94.
7. Teramo KA, Widness JA, Clemons GK, Voutilainen P, McKinlay S, Schwartz R. Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol 1987;69:710-6.
8. Reller MD, Kaplan S. Hypertrophic cardiomyopathy in infants of diabetic mothers: an update. Am J Perinatol 1988;5:353-8.
9. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004; 27:2819-23.
10. Rizzo G, Arduini D, Romanini C. Accelerated cardiac growth and abnormal cardiac flow in fetuses of type I diabetic mothers. Obstet Gynecol 1992;80:369-76.
11. Goetze JP. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 2004;50:1503-10.
12. Cameron VA, Ellmers LJ. Minireview: natriuretic peptides during development of the fetal heart and circulation. Endocrinology 2003;144:2191-4.
13. Woods RL. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Clin Exp Pharmacol Physiol 2004;31:791-4.
14. de Lemos JA, McGuire DK, Drazner MH. B-Type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-22.
15. Hirata Y, Matsumoto A, Aoyagi T, Yamaoki K, Komuro I, Suzuki T, et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res 2001;51:585-91.
16. Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageyama M, et al. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003;57:191-7.
17. Itoh H, Sagawa N, Hasegawa M, Okagaki A, Inamori K, Ihara Y, et al. Brain natriuretic peptide levels in the umbilical venous plasma are elevated in fetal distress. Biol Neonate 1993;64:18-25.
18. Fleming SM, O'Gorman T, O'Byrne L, Grimes H, Daly KM, Morrison JJ. Cardiac troponin I and N-terminal pro-brain natriuretic peptide in umbilical artery blood in relation to fetal heart rate abnormalities during labor. Pediatr Cardiol 2001;22:393-6.
19. Leipala JA, Boldt T, Turpeinen U, Vuolteenaho O, Fellman V. Cardiac hypertrophy and altered hemodynamic adaptation in growth-restricted preterm infants. Pediatr Res 2003;53:989-93.
20. Jensen DM, Molsted-Pedersen L, Beck-Nielsen H, Westergaard JG, Ovesen P, Damm P. Screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study. Am J Obstet Gynecol 2003;189:1383-8.
21. Marshall SM, Barth JH. Standardization of HbA1c measurements-a consensus statement. Diabet Med 2000;17:5-6.
22. Goetze JP, Kastrup J, Pedersen F, Rehfeld JF. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 2002;48:1035-42.
23. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003;17:1105-7.
24. Nielsen LB, Goetze JP. Letters regarding article by Bibbins-Domingo, et al. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 2005;111:e15-6.
25. Henriksen JH, Gotze JP, Fuglsang S, Christensen E, Bendtsen F, Moller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 2003:52:1511-7.
26. Yan W, Sheng N, Seto M, Morser J, Wu Q. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem 1999;274:14926-35.
27. Cameron VA, Aitken GD, Ellmers LJ, Kennedy MA, Espiner EA. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 1996;137:817-24.
28. Lindegaard ML, Olivecrona G, Christoffersen C, Kratky D, Hannibal J, Petersen BL, et al. Endothelial and lipoprotein lipases in human and mouse placenta. J Lipid Res 2005; Sep 8 [Epub ahead of print].
29. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002;60:289-93.
30. Mathiesen ER, Hilsted J, Feldt-Rasmussen B, Bonde-Petersen F, Christensen NJ, Parving HH. The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients. Diabetes 1985;34:1301-5.
31. Bisseling TM, Wouterse AC, Steegers EA, Elving L, Russel FG, Smits P. Nitric oxide-mediated vascular tone in the fetal placental circulation of patients with type 1 diabetes mellitus. Placenta 2003;24:974-8.
32. Holcberg G, Kossenjans W, Brewer A, Miodovnik M, Myatt L. The action of two natriuretic peptides (atrial natriuretic peptide and brain natriuretic peptide) in the human placental vasculature. Am J Obstet Gynecol 1995;172:71-7.
33. Holtwick R, van Eickels M, Skryabin BV, Baba HA, Bubikat A, Begrow F, et al. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte- restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 2003:111:1399-407.
34. Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A 2000;97:4239-44.